Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with squamous cell carcinoma of the cervix (a specific type of cervical cancer), confirmed by laboratory testing of tissue.
- People whose tumor is considered large, meaning it takes up a volume of 60 cc or more, or measures at least 6 cm across at its widest point.
- People who are between 19 and 80 years old at the time of their diagnosis.
- People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard medical scoring tool called the ECOG performance status (scores 0 to 2, meaning fully active to capable of limited self-care — confirm with trial site if unsure where someone falls).
- People who have freely chosen to take part in the study.
Who may not be able to join:
- People who have been diagnosed with another type of cancer within the last 5 years, with the exception of certain early-stage breast conditions (carcinoma in situ of the breast) or thyroid cancer.
- People whose overall health means they are not considered well enough to safely receive the standard combined chemotherapy and radiation treatment used in this trial.
- People who have already received chemotherapy before starting radiation therapy for this condition.
- People who have previously had radiation treatment directed at the abdomen or pelvis area.
- People who are unable to give informed consent due to a mental or physical disability.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 82-31-787-7653
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of Participants With Tumor Volume < 12 cc Before Brachytherapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.